Skip to main content
Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
2.760
-0.160 (-5.48%)
At close: Mar 31, 2025, 4:00 PM
2.770
+0.010 (0.37%)
After-hours: Mar 31, 2025, 7:45 PM EDT

Terns Pharmaceuticals Stock Forecast

TERN's stock price has decreased by -57.93% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 5 analysts with 12-month price forecasts for Terns Pharmaceuticals stock have an average target of 18.3, with a low estimate of 7.50 and a high estimate of 26. The average target predicts an increase of 563.04% from the current stock price of 2.76.

Analyst Consensus: Buy
Target Low Average Median High
Price $7.50 $18.3 $20 $26
Change +171.74% +563.04% +624.64% +842.03%
* Price targets were last updated on Dec 4, 2024.

Analyst Ratings

The average analyst rating for Terns Pharmaceuticals stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 221111
Buy 333333
Hold 111122
Sell 000000
Strong Sell 000000
Total 665566

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Andy Hsieh
William Blair
 William Blair
Hold
Initiates
n/a
 Hold Initiates n/a n/a Feb 28, 2025
Silvan Tuerkcan
JMP Securities
 JMP Securities
Buy
Reiterates
$20
 Buy Reiterates $20 +624.64% Dec 4, 2024
Jay Olson
Oppenheimer
 Oppenheimer
Buy
Maintains
$17 → $20
 Buy Maintains $17 → $20 +624.64% Dec 4, 2024
Ed Arce
HC Wainwright & Co.
 HC Wainwright & Co.
Hold
Reiterates
$7.5
 Hold Reiterates $7.5 +171.74% Dec 4, 2024
Ed Arce
HC Wainwright & Co.
 HC Wainwright & Co.
Hold
Maintains
$5.5 → $7.5
 Hold Maintains $5.5 → $7.5 +171.74% Nov 13, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.33
from -1.12
EPS Next Year
-1.43
from -1.33
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
-1.00M-----7.06M
Revenue Growth
--------
EPS
-102.93-2.21-1.67-1.27-1.12-1.33-1.43-1.59
EPS Growth
--------
Forward PE
--------
No. Analysts -----12109
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High n/a n/a 36.3M
Avg n/a n/a 7.1M
Low n/a n/a n/a

Revenue Growth

Revenue Growth 20252026202720282029
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 20252026202720282029
High -1.18 -1.26 -1.26
Avg -1.33 -1.43 -1.59
Low -1.45 -1.53 -1.91

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.